Arnaud Fekkar
Centre National de la Recherche Scientifique(FR)Inserm(FR)Sorbonne Université(FR)Assistance Publique – Hôpitaux de Paris(FR)Institut de Myologie(FR)Pitié-Salpêtrière Hospital(FR)Centre d'Immunologie et des Maladies Infectieuses(FR)
Publications by Year
Research Areas
Antifungal resistance and susceptibility, Fungal Infections and Studies, Plant Pathogens and Fungal Diseases, Nail Diseases and Treatments, Pneumocystis jirovecii pneumonia detection and treatment
Most-Cited Works
- → Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths(2021)617 cited
- → The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies(2022)183 cited
- → Occurrence of Invasive Pulmonary Fungal Infections in Patients with Severe COVID-19 Admitted to the ICU(2020)179 cited
- → Comparison of Immunoblotting, Calculation of the Goldmann-Witmer Coefficient, and Real-Time PCR Using Aqueous Humor Samples for Diagnosis of Ocular Toxoplasmosis(2008)156 cited
- → Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient(2020)138 cited
- → MALDI‐TOF MS‐based drug susceptibility testing of pathogens: The example of Candida albicans and fluconazole(2009)133 cited